Rosetta Genomics Ltd
OTC:ROSGQ
Income Statement
Earnings Waterfall
Rosetta Genomics Ltd
Revenue
|
5.8m
USD
|
Cost of Revenue
|
-4.9m
USD
|
Gross Profit
|
936k
USD
|
Operating Expenses
|
-13.7m
USD
|
Operating Income
|
-12.8m
USD
|
Other Expenses
|
-592k
USD
|
Net Income
|
-13.4m
USD
|
Income Statement
Rosetta Genomics Ltd
Sep-2006 | Dec-2006 | Dec-2007 | Sep-2008 | Dec-2008 | Sep-2009 | Dec-2009 | Sep-2010 | Dec-2010 | Sep-2014 | Dec-2014 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
0
N/A
|
0
N/A
|
0
+73%
|
0
+8%
|
0
-4%
|
1
+391%
|
3
+121%
|
8
+182%
|
9
+4%
|
9
+5%
|
9
-3%
|
9
+5%
|
5
-42%
|
6
+9%
|
|
Gross Profit | ||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(2)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(5)
|
(5)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
(0)
N/A
|
(0)
-90%
|
0
N/A
|
(0)
N/A
|
(0)
+71%
|
0
N/A
|
1
+3 429%
|
2
+233%
|
3
+47%
|
3
-3%
|
3
+5%
|
2
-40%
|
1
-70%
|
1
+72%
|
|
Operating Income | ||||||||||||||||||||
Operating Expenses |
(6)
|
(7)
|
(11)
|
(7)
|
(15)
|
(7)
|
(15)
|
(8)
|
(15)
|
(3)
|
(14)
|
(8)
|
(18)
|
(16)
|
(19)
|
(17)
|
(17)
|
(15)
|
(14)
|
|
Selling, General & Administrative |
(2)
|
(3)
|
(5)
|
(3)
|
(6)
|
(3)
|
(8)
|
(4)
|
(8)
|
(3)
|
(12)
|
(7)
|
(15)
|
(11)
|
(14)
|
(14)
|
(14)
|
(12)
|
(11)
|
|
Research & Development |
(4)
|
(4)
|
(6)
|
(4)
|
(9)
|
(4)
|
(7)
|
(3)
|
(6)
|
(0)
|
(2)
|
(1)
|
(3)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
|
Operating Income |
(6)
N/A
|
(7)
-12%
|
(11)
-66%
|
(7)
+39%
|
(14)
-108%
|
(7)
+49%
|
(15)
-108%
|
(8)
+45%
|
(15)
-86%
|
(3)
+77%
|
(14)
-316%
|
(7)
+48%
|
(16)
-113%
|
(13)
+18%
|
(16)
-25%
|
(14)
+13%
|
(16)
-11%
|
(15)
+6%
|
(13)
+13%
|
|
Pre-Tax Income | ||||||||||||||||||||
Interest Income Expense |
0
|
1
|
1
|
(5)
|
6
|
6
|
0
|
1
|
1
|
0
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(0)
|
1
|
1
|
|
Non-Reccuring Items |
0
|
0
|
(5)
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
|
Pre-Tax Income |
(6)
N/A
|
(6)
-5%
|
(15)
-138%
|
(11)
+23%
|
(9)
+16%
|
(1)
+85%
|
(15)
-946%
|
(7)
+53%
|
(15)
-110%
|
(3)
+77%
|
(15)
-332%
|
(8)
+45%
|
(17)
-119%
|
(15)
+15%
|
(18)
-22%
|
(18)
0%
|
(16)
+9%
|
(14)
+15%
|
(12)
+15%
|
|
Net Income | ||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(6)
|
(6)
|
(15)
|
(11)
|
(9)
|
(1)
|
(15)
|
(7)
|
(15)
|
(3)
|
(15)
|
(8)
|
(17)
|
(15)
|
(18)
|
(18)
|
(16)
|
(14)
|
(12)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(6)
N/A
|
(6)
-5%
|
(15)
-138%
|
(11)
+24%
|
(9)
+16%
|
(2)
+75%
|
(17)
-609%
|
(7)
+59%
|
(15)
-118%
|
(3)
+77%
|
(15)
-332%
|
(8)
+45%
|
(17)
-119%
|
(15)
+15%
|
(18)
-23%
|
(18)
0%
|
(16)
+10%
|
(15)
+9%
|
(13)
+9%
|
|
EPS (Diluted) |
-292.99
N/A
|
-308
-5%
|
-733
-138%
|
-560.5
+24%
|
-473
+16%
|
-116.5
+75%
|
-825.5
-609%
|
-339
+59%
|
-738
-118%
|
-3.5
+100%
|
-15.51
-343%
|
-6.43
+59%
|
-13.79
-114%
|
-8.54
+38%
|
-10.4
-22%
|
-10.42
0%
|
-9.31
+11%
|
-6.16
+34%
|
-5.25
+15%
|